VXLLF (Vaxil Bio) Common Stock: $11.76 Mil (As of Mar. 2026)


VXLLF Vaxil Bio Ltd VXLLF
38 GF Score
Price $0.02
! 2 Warning Signs
View Full Analysis

What is Vaxil Bio Common Stock?

Vaxil Bio VXLLF -85.27% 38 Common Stock is $11.76 Mil as of Mar. 2026. GuruFocus rates VXLLF with a GF Score™ of 38/100. The stock has 2 warning signs investors should review.

Vaxil Bio's quarterly common stock increased from Sep. 2025 ($11.62 Mil) to Dec. 2025 ($11.69 Mil) and increased from Dec. 2025 ($11.69 Mil) to Mar. 2026 ($11.76 Mil).

Vaxil Bio's annual common stock declined from Dec. 2023 ($11.98 Mil) to Dec. 2024 ($11.28 Mil) but then increased from Dec. 2024 ($11.28 Mil) to Dec. 2025 ($11.69 Mil).


Vaxil Bio Common Stock Historical Data

* Premium members only.

The historical data trend for Vaxil Bio's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaxil Bio Common Stock Chart

Vaxil Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.56 11.83 11.98 11.28 11.69

Vaxil Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.20 11.76 11.62 11.69 11.76
VXLLF
38GF Score
Vaxil Bio Ltd VXLLF
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaxil Bio Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $11.76 Mil mean?
Vaxil Bio (VXLLF) has a Common Stock of $11.76 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Vaxil Bio and its competitors.
Is Vaxil Bio's Common Stock too high?
Vaxil Bio's current Common Stock is $11.76 Mil. Overall, Vaxil Bio has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Vaxil Bio's Common Stock compare to VRTX and REGN?
Vaxil Bio's Common Stock of $11.76 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Vaxil Bio and its competitors. Vaxil Bio's current Common Stock is $11.76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxil Bio stock overvalued right now?
Vaxil Bio (VXLLF) has a current Common Stock of $11.76 Mil. The current Common Stock is $11.76 Mil. Vaxil Bio's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Vaxil Bio (VXLLF), the current Common Stock is $11.76 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vaxil Bio Business Description

Other Exchanges VXL:Canada
Address 559 Briar Hill Avenue, Toronto, ON, CAN, M5N 1N1
Vaxil Bio Ltd is a biotechnology company focused on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. In recent years, the Company has been more focused on P-EsbpDOX. The Company develops ImMucin, a MUC1 SP-derived vaccine that has completed a Phase 1/2 clinical trial for the treatment of multiple myeloma. It is also developing SP-based COVID-19 and tuberculosis vaccine/treatment candidates.
38GF Score

Get the complete analysis for VXLLF

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.02
Price